{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:02Z","timestamp":1790677382950,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00415-014-7402-z","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T11:28:04Z","timestamp":1406374084000},"page":"1684-1690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis"],"prefix":"10.1007","volume":"261","author":[{"given":"Thomas","family":"Hundsberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai M.","family":"R\u00f6sler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"7402_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"key":"7402_CR2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, Moggio M, Filosto M, Sette E, Crescimanno G, Tonin P, Parini R, Morandi L, Marrosu G, Greco G, Musumeci O, Di IG, Siciliano G, Donati MA, Carubbi F, Ermani M, Mongini T, Toscano A (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4\u00a0years. J Neurol 259:952\u2013958","journal-title":"J Neurol"},{"key":"7402_CR3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/WNL.0b013e31818da93f","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, Musumeci O, Parenti G, Ravaglia S, Seidita F, Toscano A, Vianello A (2008) Management and treatment of glycogenosis type II. Neurology 71:S12\u2013S36","journal-title":"Neurology"},{"key":"7402_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","volume":"33","author":"B Bembi","year":"2010","unstructured":"Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R, Rigoldi M, Moglia A, Costa A, Carlucci A, Danesino C, Pittis MG, Dardis A, Ravaglia S (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33:727\u2013735","journal-title":"J Inherit Metab Dis"},{"key":"7402_CR5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.rmed.2006.01.001","volume":"100","author":"A Chetta","year":"2006","unstructured":"Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, Olivieri D (2006) Reference values for the 6-min walk test in healthy subjects 20\u201350\u00a0years old. Respir Med 100:1573\u20131578","journal-title":"Respir Med"},{"key":"7402_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1750-1172-7-73","volume":"7","author":"JM Vries de","year":"2012","unstructured":"de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber CG, Verschuuren JJ, Kruijshaar ME, Reuser AJ, van Doorn PA, van der Ploeg AT (2012) Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study. Orphanet J Rare Dis 7:73","journal-title":"Orphanet J Rare Dis"},{"key":"7402_CR7","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00415-013-6980-5","volume":"260","author":"T Hundsberger","year":"2013","unstructured":"Hundsberger T, Rohrbach M, Kern L, Rosler KM (2013) Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease. J Neurol 260:2279\u20132285","journal-title":"J Neurol"},{"key":"7402_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ymgme.2012.08.013","volume":"107","author":"A Jurecka","year":"2012","unstructured":"Jurecka A, Zuberuber Z, Opoka-Winiarska V, Wegrzyn G, Tylki-Szymanska A (2012) Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature. Mol Genet Metab 107:508\u2013512","journal-title":"Mol Genet Metab"},{"key":"7402_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE (2007) Recombinant human acid a-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68:99\u2013109","journal-title":"Neurology"},{"key":"7402_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","volume":"160C","author":"M Kroos","year":"2012","unstructured":"Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ (2012) The genotype-phenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet 160C:59\u201368","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"7402_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1750-1172-8-160","volume":"8","author":"R Lachmann","year":"2013","unstructured":"Lachmann R, Schoser B (2013) The clinical relevance of outcomes used in late-onset Pompe disease: can we do better? Orphanet J Rare Dis 8:160\u2013172","journal-title":"Orphanet J Rare Dis"},{"key":"7402_CR12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0b013e318228c0ea","volume":"77","author":"K Laloui","year":"2011","unstructured":"Laloui K, Wary C, Carlier RY, Hogrel JY, Caillaud C, Laforet P (2011) Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat? Neurology 77:594\u2013595","journal-title":"Neurology"},{"key":"7402_CR13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mus.23658","volume":"47","author":"DS Lin","year":"2013","unstructured":"Lin DS, Chiang MF, Ho CS, Hsiao CD, Lin CY, Wang NL, Chuang CK, Huang YW, Chang PC, Liu HL (2013) Low-frequency enzyme replacement therapy in late-onset Pompe disease. Muscle Nerve 47:612\u2013613","journal-title":"Muscle Nerve"},{"key":"7402_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajmg.c.31317","volume":"160","author":"N Raben","year":"2012","unstructured":"Raben N, Wong A, Ralston E, Myerowitz R (2012) Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am J Med Genet C Semin Med Genet 160:13\u201321","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"7402_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10545-012-9451-8","volume":"35","author":"C Regnery","year":"2012","unstructured":"Regnery C, Kornblum C, Hanisch F, Vielhaber S, Strigl-Pill N, Grunert B, Muller-Felber W, Glocker FX, Spranger M, Deschauer M (2012) 36\u00a0months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. J Inherit Metab Dis 35:837\u2013845","journal-title":"J Inherit Metab Dis"},{"key":"7402_CR16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","volume":"5","author":"B Schoser","year":"2008","unstructured":"Schoser B, Hill V, Raben N (2008) Therapeutic approaches in glycogen storage disease type II\/Pompe disease. Neurotherapeutics 5:569\u2013578","journal-title":"Neurotherapeutics"},{"key":"7402_CR17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2165\/11635320-000000000-00000","volume":"72","author":"S Simoens","year":"2012","unstructured":"Simoens S, Cassiman D, Dooms M, Picavet E (2012) Orphan drugs for rare diseases: is it time to revisit their special market access status? Drugs 72:1437\u20131443","journal-title":"Drugs"},{"key":"7402_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"S Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, Muller-Felber W, Mengel E, Spranger M, Schoser B (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91\u201397","journal-title":"J Neurol"},{"key":"7402_CR19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Lynch MC, Vaccaro C, Afonso K, Tsai AC, Bossen E, Kishnani PS, O\u2019Callaghan M (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86:1208\u20131220","journal-title":"Lab Invest"},{"key":"7402_CR20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951\u2013959","journal-title":"J Neurol"},{"key":"7402_CR21","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JM Hout van den","year":"2004","unstructured":"van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, Van HH, van Diggelen OP, Boer M, Kroos MA, van Doorn PA, Van der Voort E, Sibbles B, Van Corven EJ, Brakenhoff JP, Van Hove J, Smeitink JA, de Jong G, Reuser AJ, van der Ploeg AT (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113:e448\u2013e457","journal-title":"Pediatrics"},{"key":"7402_CR22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-7-88","volume":"7","author":"NA Beek van der","year":"2012","unstructured":"van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, de Visse M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber KG, Verschuuren JJ, Reuser AJ, van der Ploeg AT, van Doorn PA (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 7:88","journal-title":"Orphanet J Rare Dis"},{"key":"7402_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","volume":"19","author":"NA Beek van der","year":"2009","unstructured":"van der Beek NA, Hagemans ML, Reuser AJ, Hop WC, van der Ploeg AT, van Doorn PA, Wokke JH (2009) Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 19:113\u2013117","journal-title":"Neuromuscul Disord"},{"key":"7402_CR24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg van der","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362:1396\u20131406","journal-title":"N Engl J Med"},{"key":"7402_CR25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Ploeg van der","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ (2008) Pompe\u2019s disease. Lancet 372:1342\u20131353","journal-title":"Lancet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7402-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7402-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7402-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:22:40Z","timestamp":1559056960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7402-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["7402"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7402-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]}}}